NEW YORK, April 19 –Genomic Solutions and PerkinElmer have settled a lawsuit over PerkinElmer’s stake in Genomic Solutions stock, the companies said Thursday. 

Genomic Solutions also released financial results for the first quarter of 2001 Thursday, reporting that revenues increased 10 percent over the year-ago quarter to $4.4 million, and that losses totaled 12 cents per share, 4 cents more than Wall Street had expected, according to a survey of one broker conducted by FirstCall/Thomson Financial.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York Times and ProPublica say that many physicians fail to disclose their financial ties when publishing in medical journals.

The Wall Street Journal reports Human Longevity's valuation has dropped by 80 percent.

Science reports that the US National Cancer Institute is cutting its operating budget by 5 percent.

In PLOS this week: similar variants seen in bullbogs, people with Robinow syndrome; ApoE genotypes in African-American, Puerto Rican populations; and more.